CLINICAL TRIALS PROFILE FOR RITANSERIN
✉ Email this page to a colleague
Clinical Trials for Ritanserin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00000187 ↗ | Ritanserin in Treatment of Cocaine Dependence - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence. |
NCT00000187 ↗ | Ritanserin in Treatment of Cocaine Dependence - 1 | Completed | University of Pennsylvania | Phase 2 | The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence. |
NCT00206765 ↗ | Risperidone vs. Paroxetine for Panic Attacks | Terminated | Beth Israel Medical Center | Phase 2 | We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Ritanserin
Condition Name
Clinical Trial Locations for Ritanserin
Trials by Country
Clinical Trial Progress for Ritanserin
Clinical Trial Phase
Clinical Trial Sponsors for Ritanserin
Sponsor Name